Anlon Healthcare Q2 FY26: revenue up 116% YoY, but operating cash flow turns negative

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹14.31

prior close

₹14.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+2.2% vs market

Pharmaceuticals peers, median of 157sector-0.2%+2.2% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.8

10m

+3.5

15m

+5.3

30m

+4.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.3+2.2-0.2+2.2

Next day

-1.6+0.7-2.3+0.5-2.1

+0.2+0.6-0.4+0.6-0.4

-0.8+0.5-1.3+0.5-1.3

+4.8+1.1+3.7+0.2+4.6

+10.1+0.3+9.9-0.6+10.8

+9.3-0.2+9.5-1.1+10.4

15d

+10.0-2.2+12.2-2.1+12.1

-1.3-4.9+3.6-3.2+1.9

-5.0-7.5+2.5-5.9+1.0

-14.0-4.8-9.3-6.4-7.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anlon Healthcare Q2 FY26 revenue jumped 116% YoY to Rs 5,220.13 lakhs. H1 FY26 revenue grew 38% to Rs 8,549.85 lakhs. PAT rose to Rs 931.73 lakhs in Q2 from Rs 259.23 lakhs. EBITDA margin however fell from about 31% to 26%. Operating cash flow for H1 was negative Rs 7,787.25 lakhs on working capital build-up. Listed on NSE/BSE on Sept 3, 2025.

Likely market impact

Strong top line and profit growth, but negative operating cash flow and margin compression signal working capital pressure. Monitor receivables.